Our results suggest that when a PPARα agonist is treated in animals with hyperlipidemia and fatty liver, pexophagy occurs in the liver due to peroxisome proliferation, which may result in residual peroxisomal processing. This evidence concerns the gene PPARA and hyperlipidemia.